Interventional MR: interstitial therapy

• Published in: European radiology 1999-01, Vol.9 (8), p.1479-1487
• Main Authors: Vogl, T J, Mack, M G, Müller, P K, Straub, R, Engelmann, K, Eichler, K
• Format: Article
• Language: English
• Subjects: Abdominal Neoplasms - therapy; Cancer; Catheter Ablation; Confidence intervals; Female; Head and Neck Neoplasms - therapy; Humans; Hyperthermia, Induced; Laser Therapy; Liver Neoplasms - secondary; Liver Neoplasms - therapy; Magnetic Resonance Imaging - methods; Male; Middle Aged; Neoplasm Recurrence, Local - therapy; Radiology, Interventional; Survival Rate; Tumors
• ISSN: 0938-7994; 1432-1084
• DOI: 10.1007/s003300050874

The rationale and results for interstitial therapies via interventional MRI in the treatment of tumors in various regions are presented. Different interstitial treatment techniques are presented based on varying technologies both for tumor ablation and treatment monitoring. Data are presented based on 335 patients, 29-84 years of age (mean age 59 years, 196 men and 139 women) with a total of 932 liver tumors, 16 head and neck tumors and 14 abdominal recurrent pelvic and lymphatic tumors. All lesions had been treated with MR-guided laser-induced interstitial thermotherapy (LITT) via 2516 laser applications and 1856 cannulations. Data in the literature are extremely varying depending on author experience, treatment technique, and the included patient material. In our patient material we were able to achieve a local tumor control of 96.7% depending on the size of the tumorous lesion, the topographical relationship, and the applied laser parameters. The overall cumulative survival rate of patients with liver metastases was 45.74 months (median 40.97 months, 95 % confidence interval 31.42-50.52). The cumulative survival rate of the patient group with hepatic metastases of colorectal carcinoma was 42.71 months (median 39.33 months, 95% confidence interval 33.26-45.37). In patients with head and neck tumors a relevant reduction in clinically relevant symptoms such as pain, swallowing disorders, or nervous compression was achieved in 11 of 15 patients treated with LITT. In 14 soft tissue tumors, such as pelvic tumor recurrence and lymph node metastases, a local tumor control was obtained in 68% of lesions. Interstitial therapies under interventional MRI guidance, such as LITT, results in a high local tumor control with an improved survival rate.